Nfkbid - NFKB inhibitor delta Gene
Also Known as Ta-nfkbh; RGD1308055
Species: Rattus norvegicus
Summary
Predicted to enable NF-kappaB binding activity. Predicted to be involved in T cell receptor signaling pathway; positive regulation of T-helper 17 cell differentiation; and regulation of gene expression. Predicted to act upstream of or within several processes, including negative regulation of NF-kappaB transcription factor activity; negative regulation of T cell differentiation in thymus; and positive regulation of thymocyte apoptotic process. Predicted to be active in nucleus. Orthologous to human NFKBID (NFKB inhibitor delta). [provided by Alliance of Genome Resources, Apr 2022]
Nfkbid Products (7)
| mRNA | Protein | Name |
|---|---|---|
| XM_039093859.1 | XP_038949787.1 | NF-kappa-B inhibitor delta isoform X2 |
| XM_039093851.1 | XP_038949779.1 | NF-kappa-B inhibitor delta isoform X1 |
| XM_039093863.1 | XP_038949791.1 | NF-kappa-B inhibitor delta isoform X5 |
| XM_006228804.4 | XP_006228866.1 | NF-kappa-B inhibitor delta isoform X3 |
| XM_039093862.1 | XP_038949790.1 | NF-kappa-B inhibitor delta isoform X4 |
| XM_039093856.1 | XP_038949784.1 | NF-kappa-B inhibitor delta isoform X1 |
| XM_039093857.1 | XP_038949785.1 | NF-kappa-B inhibitor delta isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NF-kappa-B inhibitor delta |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS09262 | NFKBID Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service